We retrospectively examined the contrast enhanced T1-weighted MRI imaging of a large cohort (n = 587) of exclusively IDH mutant glioma patients, identified all instances of CEnew, and determined the incidence, characteristics, and survival implications of CEnew, PsP, and TP. This evidence concerns the gene IDH1 and glioma.